With the addition of Ganirelix, Ferring continues to offer the most complete reproductive medicine portfolio available, which includes MENOPUR ® (menotropins for injection), NOVAREL ® (chorionic ...

Today Ferring Pharmaceuticals announced results from MEGASET HR, a 620 patient, prospective study comparing MENOPUR (highly purified menotropin, or HP-hMG) to recombinant follicle ...

PARSIPPANY, N.J. — Ferring Pharmaceuticals announced that it received approval from the Food and Drug Administration for new labeling of its fertility products Menopur and Bravelle.

Ferring Pharmaceuticals will present five abstracts at the 2019 American Society for Reproductive Medicine ... Menopur (menotropins for injection), administered subcutaneously, ...

Patients received either MENOPUR or rFSH by sub-cutaneous injection, ... Ferring is a Swiss-based research driven, specialty biopharmaceutical Group active in global markets.

Ferring Pharmaceuticals announced that the FDA has approved a new labeling for Menopur (menotropins for injection) and Bravelle (urofollitropin for injection) stating that both products can be ...

Ferring Pharmaceuticals has suspended all shipments of its key fertility drug, Menopur. Insider obtained a memo Ferring Pharmaceuticals sent to healthcare providers. The company said in the memo ...

Ferring Pharmaceuticals has suspended all shipments of its key fertility drug, Menopur. Insider obtained a memo Ferring Pharmaceuticals sent to healthcare providers. The company said in the memo ...

IVF treatment with Ferring’s Menopur yields a significantly higher live birth rate than that achieved with Serono’s recombinant follicle stimulating hormone product Gonal F (follitropin alfa), ...

Women worldwide who count on Ferring Pharmaceutical’s flagship fertility drug may be out of luck for the foreseeable future. Ferring Pharmaceuticals has paused global shipments of the injectable ...